Led by a group of nationally and internationally recognized physicians, the Interventional Cardiology service provides state of the art facilities for a full spectrum of coronary, structural heart, and peripheral vascular interventions (PVI).
Areas of interest include complex coronary angioplasty, structural heart interventions such as transcatheter aortic valve (TAVR) and mitral interventions, and peripheral vascular disease therapies. The peripheral vascular service includes a multidisciplinary limb salvage program and one of the largest carotid programs nationwide.
The Yale Interventional Cardiology Program has an established history as a leader in cardiovascular catheterization and intervention providing state of the art care for patients in the New England area, and as a national and international referral center for complex percutaneous interventional procedures in the structural heart and peripheral spaces. The Yale Interventional team services Yale New Haven Health System which encompasses (Yale New Haven Hospital, Greenwich Hospital, Lawrence and Memorial Hospital, Bridgeport Hospital), the West Haven Veterans Affairs Medical Center.
Yale Interventional cardiology is focused on global cardiovascular patient care with specialists in complex coronary disease, structural heart disease, and peripheral vascular diseases. We both lead and participate in a variety of clinical trials to develop devices and techniques to manage the unmet patient needs in cardiovascular medicine. Our research team is engaged in clinical investigation locally and also has global reach via our investigational team, infrastructure, and core laboratories with Yale Cardiovascular Research Group (YCRG). We have developed international affiliations with major academic center including The Barts Heart Institute in London, England, the University of Athens Medical School in Greece, providing synergies in clinical medicine, research, and education world-wide. The overall goal of these programs is to provide a framework to enhance research and development by providing an infrastructure and network for academic research and vertical device development, from bench to regulatory approval.
From the early history of interventional cardiology, Yale has been a recognized leader in the field with among the world’s first applications of rotational atherectomy, coronary stents, and brachytherapy to the current era of advanced coronary revascularization, transcatheter valve repair and replacement, and endovascular patient care including limb-salvage and complex peripheral interventions. Through involvement in developing and delivering these technologies, our team at Yale is excited to live in a fun, innovative, and rapidly evolving time in interventional cardiology.
Clinical practice, research, and training in interventional cardiology takes place primarily in the catheterization laboratories on the two campuses of Yale New Haven Hospital and at the West Haven Veterans Affairs Hospitals. The flagship Yale New Haven Hospital’s Interventional Suites include 7 adult and pediatric, and 2 hybrid OR-Cath lab suites. Within the interventional cardiology cath labs reside one Phillips FD 10/10 hybrid biplane room (scaled for adult congential-structural, transcatheter aortic valve, and adult coronary procedures), two rooms with ceiling mounted Siemens Artis Zee flat detectors and large 56” multimodality image display, one coronary-peripheral vascular interventional suite with Siemens Artis Zeego with large detector and image display and full peripheral capabilities, and a large flat panel, GE solutions coronary-vascular interventional room.
Yale New Haven Hospital performs ~10,000 diagnostic procedures and ~2000 coronary interventional procedures/cases annually. Yale Interventional cardiology accounts for ~75% of the procedural volume at the flagship Yale New Haven Hospital, and fully supports coronary and peripheral vascular interventions throughout the health system and at the West Haven VA Medical Center. Yale Interventional Cardiology is equipped with state-of-the-art technologies and practices leading edge percutaneous intervention.
Directed by Robert Attaran, MD (deputy director Ryan Kaple, MD) the Interventional Cardiology Fellowship is a one-year ACGME-accredited program that is performed upon completion of a three-year fellowship in Cardiovascular Disease. The main objective of the Fellowship Training Program in Interventional Cardiology is to provide an academically and clinically rigorous training program for the cardiology trainee to obtain the necessary skills and judgement in cardiac interventional procedures. The program is undergoing restructuring and will be extended to a 2-year advanced training model in the future. Applicants will have the opportunity to apply to a rigorous training program, the first year of which will consist of interventional cardiology and the second year, a choice of structural, peripheral vascular or research.
The program is comprised of:
- Four ACGME accredited positions for focused 1-year training in Interventional Cardiology
- Two Yale Continuing Non-ACGME accredited positions in an Advanced Interventional Cardiology Fellowship in Structural Heart Disease
- Four Yale Non-ACGME accredited positions in a Peripheral Vascular Interventions Fellowship
As the first cath lab in the northeast to use rotational atherectomy, and the first in New England to place an intracoronary stent, Yale has a tradition of research innovation. Led by Alexandra Lansky, MD, Director of the Clinical Research Program, Yale participates in a variety of multicenter clinical trials including:
- Evaluation of novel drug eluting balloons
- Biodegradable coronary stent and scaffolds
- Dedicated bifurcation stents
- Novel therapies for coronary chronic total occlusion
- Percutaneous valve therapies
- Intravascular imaging
- Modalities for cardiac biologic repair
15th Annual Critical Limb Ischemia Summit live case at NCVH
Cardiovascular Innovations 2019
Associate Professor; Director Interventional Cardiology Fellowship, Cardiovascular Medicine; Director Endovascular Fellowship, Cardiovascular Medicine
Professor Emeritus of Medicine (Cardiology); Associate Section Chief Cardiovascular Medicine, Internal Medicine; Medical Director Network Development, Yale Medicine; Medical Director YNHH Heart and Vascular Center
Associate Professor of Clinical Medicine; Medical Director, Yale Heart and Vascular Center, L+M Hospital, Westerly Hospital; Director, Yale Primary Angioplasty Program at Lawrence and Memorial Hospital, Cardiovascular Medicine
Professor of Medicine (Cardiology)
Professor of Medicine (Cardiovascular Medicine); Medical Director, Performance Improvement, Heart & Vascular Center; Senior Scientific Advisor, NCDR; Director, Registry Data Analytic Center, Center for Outcomes Research & Evaluation (CORE)
Assistant Professor of Clinical Medicine
Associate Professor of Medicine (Cardiovascular Medicine); Director of Interventional Cardiology, Cardiovascular Medicine; Director of Structural Heart Disease, Yale Medicine; Director, Structural Heart Disease Program, Cardiovascular Medicine
Associate Professor of Medicine (Cardiology)
Assistant Professor of Clinical Medicine; Physician Advisor, Yale-New Haven Hospital; Medical Director, Safety & Performance Improvement HVC; Co-Chair, Pharmacy & Therapeutics Anticoagulation & Cardiology Subcommittee; Associate Clinical Professor of Medicine, Yale School of Medicine
Assistant Professor of Clinical Medicine; Director Complex Coronary Interventions, Interventional Cardiology Program; Medical Director
Associate Professor of Medicine; Medical Director: YNHH HVC:Greenwich, Cardiovascular Medicine; Chairman Medical Executive Committee, Medical Staff; Chief of Cardiology, Greenwich Hospital, Cardiovascular Medicine; Director of Cardiac Catheterization and Intervention, Greenwich Hospital, Cardiovascular Medicine; Attending Physician Yale New Haven Hopsital Cardiac Catheterization Lab., Cardiovascular Medicine
Assistant Professor of Clinical Medicine; Clinician
Professor of Medicine (Cardiology); Director, Cardiology; Director of Yale UCLP Clinical Research Program Yale University School of Medicine, New Haven, CT, The Barts Heart Center and Queen Mary University of London, Cardiology
Associate Professor of Medicine (Cardiology); Director CME, Section of Cardiology, Internal Medicine; Co-Director Limb Preservation Program, Yale New Haven Health System; Honorary Clinical Reader in Centre, Clinical Pharmacology in the William Harvey Research Institute; Co-Director Vascular Outcomes Program, Internal Medicine; Primary Member, Yale Institutional Review Board; Consultant, Center For Devices and Radiological Health; Member, Yale School of Medicine Progress Committee; Medical Director Vascular Medicine - YNHH, Internal Medicine
Assistant Professor of Medicine (Cardiovascular Medicine); Member - HVC Cath Lab Performance Improvement Committee, Cardiovascular Medicine
Professor of Clinical Medicine; Cardiology Section Chief, VA Connecticut, VA Connecticut Healthcare System
Assistant Professor of Clinical Medicine
Associate Professor of Medicine (Cardiology); Director, Goodyer Cardiology Teaching Firm; Medical Director